BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/11/1994

NIH to Consider Partially Exclusive Patent License for Ophthalmology Treatments

The National Institutes of Health (NIH) is seeking public comment on a proposed license to practice certain ophthalmology treatments, including those related to purified transforming growth factor beta, with Celtrix Pharmaceuticals Inc. of Santa Clara, California.

Source: Federal Register — Health and Human ServicesOpen original release →